E-ISSN 2577-5669
 
2020, Vol: 11, Issue: 4
11/4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Cover Letter
Title Page

Original Research 


Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi.

Abstract
Background: Brucellosis is an ecumenical problem and irresistible illness that can influence a sizably voluminous population in creating nations and common between creatures and people. There are many procedures for diagnosing and recognition of Brucella spp. such as microbiological, serological, and molecular assays. This consider looked for to identify Brucella disease in human serum by both serological and molecular methods. In the intense and sub-acute stages of the infections, to access a corroborate diagnosis, it is needed to the confinement of Brucella from clinical tests which is the foremost delicate assay. When the titers of the patient's antibody are lower than 160 or antibodies that cross-react with other bacteria have existed or the illness comes to chronic localized cases, nucleic acid amplification tests (NAATs) such as PCR are more sensitive and specific than serology methods.
Materials and Methods: For the determination of Brucella spp. the sensitivity and specificity of the B4-B5 primers and designed IS711 primers were assessed and contrasted with the outcome of the 2ME test within the clinical specimens of 49 suspected patients.
Results: The comes about uncovered that from 49 serum sample in 2ME test only 45(91.83%) samples were positive, the amplicon of BCSP31-PCR was 223 bp and all the 49 (100%) serum samples, and the amplicon of the designed IS711-PCR was 448 bp length and 46 of 49 (93.87%) serum specimens were positive. The outcomes showed that the slightest number of both Brucella melitensis and Brucella abortus 0.05 CFU/reaction could be recognized by the B4-B5 primers.
Conclusion: The sensitivity of the designed primers of IS711 is 94%, whereas the sensitivity of B4-B5 primers is 100%, and the specificity of the 2 primer pairs is 100%.

Key words: Human brucellosis, 2ME, PCR, Brucella melitensis, Blood and Serum samples.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedram H.Heidari
Articles by Mohamad Reza Razavi
Articles by Mitra Salehi
Articles by Abbas Akhavan Sepahi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. J Complement Med Res. 2020; 11(3): 74-85. doi:10.5455/jcmr.2020.11.03.10

Web Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. http://www.jocmr.com/?mno=10873 [Access: January 06, 2021]. doi:10.5455/jcmr.2020.11.03.10

AMA (American Medical Association) Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. J Complement Med Res. 2020; 11(3): 74-85. doi:10.5455/jcmr.2020.11.03.10


Vancouver/ICMJE Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. J Complement Med Res. (2020), [cited January 06, 2021]; 11(3): 74-85. doi:10.5455/jcmr.2020.11.03.10


Harvard Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi (2020) Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. J Complement Med Res, 11 (3), 74-85. doi:10.5455/jcmr.2020.11.03.10


Turabian Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. 2020. Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. Journal of Complementary Medicine Research, 11 (3), 74-85. doi:10.5455/jcmr.2020.11.03.10


Chicago Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. "Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease." Journal of Complementary Medicine Research 11 (2020), 74-85. doi:10.5455/jcmr.2020.11.03.10


MLA (The Modern Language Association) Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi. "Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease." Journal of Complementary Medicine Research 11.3 (2020), 74-85. Print. doi:10.5455/jcmr.2020.11.03.10


APA (American Psychological Association) Style

Pedram H.Heidari, Mohamad Reza Razavi, Mitra Salehi, Abbas Akhavan Sepahi (2020) Evaluation of Human Brucellosis Prevalence in the Studied Regions of Iran, in Patients with Clinical Symptoms Compatible with this Disease. Journal of Complementary Medicine Research, 11 (3), 74-85. doi:10.5455/jcmr.2020.11.03.10


Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights) Privacy Policy Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information
Copyright © 2021 Journal of Complementary Medicine Research All Rights Reserved. Subject to change without notice from or liability to Journal of Complementary Medicine Research.
For best results, please use Internet Explorer or Google Chrome

Contact Information


Journal of Complementary Medicine Research

C/O Sukasiree Publication,
3990 Hillsboro Pike, Suite 330
Nashville,USA

Email : editorjocmr@gmail.com